The global CRISPR and CRISPR-Associated (Cas) Genes revenue was US$ 1384.4 million in 2022 and is forecast to a readjusted size of US$ 9813.2 million by 2029 with a CAGR of 31.9% during the review period (2023-2029).

and India CRISPR and CRISPR-Associated (Cas) Genes Market

This report studies the CRISPR And CRISPR-Associated (Cas) Genes market.

Clustered regularly interspaced short palindromic repeats (CRISPR) are segments of prokaryotic DNA containing short repetitions of base sequences. Each repetition is followed by short segments of "spacer DNA" from previous exposures to a bacteriophage virus or plasmid.

The CRISPR/Cas system is a prokaryotic immune system that confers resistance to foreign genetic elements such as those present within plasmids and phages, and provides a form of acquired immunity. CRISPR associated proteins (Cas) use the CRISPR spacers to recognize and cut these exogenous genetic elements in a manner analogous to RNA interference in eukaryotic organisms. CRISPRs are found in approximately 40% of sequenced bacterial genomes and 90% of sequenced archaea.

Cas9 was the first nuclease discovered, followed by Cpf1, which was discovered in the CRISPR/Cpf1 system of Francisella novicida. Other such systems are thought to exist. CRISPR/Editas Medicinec2 from the bacterium Leptotrichia shahii is RNA-guided CRISPR system that targets RNA rather than DNA, and can either cleave single-stranded RNA targets or knock them down.

By delivering the Cas9 nuclease complexed with a synthetic guide RNA (gRNA) into a cell, the cell's genome can be cut at a desired location, allowing existing genes to be removed and/or new ones added. The Cas9-gRNA complex corresponds with the CAS III crRNA complex in the above diagram. CRISPR/Cas genome editing techniques have many potential applications, including altering the germline of humans, animals, and food crops. The use of CRISPR Cas9-gRNA complex for genome editing was the AAAS's choice for breakthrough of the year in 2015. Bioethical concerns have been expressed about the prospect of using this nascent biotechnology for editing the human germline.

In India, the CRISPR and CRISPR-Associated (Cas) Genes revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period 2023-2029.

Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics and Intellia therapeutics, Inc. are the top 5 players of CRISPR and CRISPR-Associated (Cas) Genes, with about 63% market shares.

CRISPR And CRISPR-Associated (Cas) Genes industry is relatively concentrated, manufacturers are mostly in the Europe and North America. Among them, North America region accounted for more than 45% of the total market of global CRISPR And CRISPR-Associated (Cas) Genes.

This report focuses on global and India CRISPR and CRISPR-Associated (Cas) Genes market, also covers the segmentation data of other regions in regional level and county level.

India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.

India is a market full of opportunities, and the demand for CRISPR and CRISPR-Associated (Cas) Genes will continue to grow rapidly in the future.

Global CRISPR and CRISPR-Associated (Cas) Genes Scope and Market Size

CRISPR and CRISPR-Associated (Cas) Genes market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global CRISPR and CRISPR-Associated (Cas) Genes market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2029.

For India market, this report focuses on the CRISPR and CRISPR-Associated (Cas) Genes market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India CRISPR and CRISPR-Associated (Cas) Genes Market Report

Report Metric	Details
Report Name	and India CRISPR and CRISPR-Associated (Cas) Genes Market
Forecasted market size in 2029	US$ 9813.2 million
CAGR	31.9%
Forecasted years	2023 - 2029
Segment by Type	Genome Editing Genetic engineering gRNA Database/Gene Librar CRISPR Plasmid Human Stem Cells Genetically Modified Organisms/Crops Cell Line Engineering
Segment by Application	Biotechnology Companies Pharmaceutical Companies Academic Institutes Research and Development Institutes
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics, Intellia therapeutics, Inc., Cellectis, Horizon Discovery Plc, Sigma Aldrich, Precision Biosciences, Genscript, Sangamo Biosciences Inc., Lonza Group Limited, Integrated DNA Technologies, New England Biolabs, Origene Technologies
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India CRISPR and CRISPR-Associated (Cas) Genes Market size in 2029?

Ans: The and India CRISPR and CRISPR-Associated (Cas) Genes Market size in 2029 will be US$ 9813.2 million.

What is the market share of major companies in and India CRISPR and CRISPR-Associated (Cas) Genes Market?

Ans: Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics and Intellia therapeutics, Inc. are the top 5 players of CRISPR and CRISPR-Associated (Cas) Genes, with about 63% market shares.

What is the and India CRISPR and CRISPR-Associated (Cas) Genes Market share by region?

Ans: According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India CRISPR and CRISPR-Associated (Cas) Genes Market report?

Ans: The main players in the and India CRISPR and CRISPR-Associated (Cas) Genes Market are Thermo Fisher Scientific, Editas Medicine, Caribou Biosciences, CRISPR therapeutics, Intellia therapeutics, Inc., Cellectis, Horizon Discovery Plc, Sigma Aldrich, Precision Biosciences, Genscript, Sangamo Biosciences Inc., Lonza Group Limited, Integrated DNA Technologies, New England Biolabs, Origene Technologies

What are the Application segmentation covered in the and India CRISPR and CRISPR-Associated (Cas) Genes Market report?

Ans: The Applications covered in the and India CRISPR and CRISPR-Associated (Cas) Genes Market report are Biotechnology Companies, Pharmaceutical Companies, Academic Institutes, Research and Development Institutes

What are the Type segmentation covered in the and India CRISPR and CRISPR-Associated (Cas) Genes Market report?

Ans: The Types covered in the and India CRISPR and CRISPR-Associated (Cas) Genes Market report are Genome Editing, Genetic engineering, gRNA Database/Gene Librar, CRISPR Plasmid, Human Stem Cells, Genetically Modified Organisms/Crops, Cell Line Engineering

1 Study Coverage

1.1 CRISPR and CRISPR-Associated (Cas) Genes Product Introduction

1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Outlook 2018 VS 2022 VS 2029

1.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size for the Year 2018-2029

1.2.2 India CRISPR and CRISPR-Associated (Cas) Genes Market Size for the Year 2018-2029

1.3 CRISPR and CRISPR-Associated (Cas) Genes Market Size, India VS Global, 2018 VS 2022 VS 2029

1.3.1 The Market Share of India CRISPR and CRISPR-Associated (Cas) Genes in Global, 2018 VS 2022 VS 2029

1.3.2 The Growth Rate of CRISPR and CRISPR-Associated (Cas) Genes Market Size, India VS Global, 2018 VS 2022 VS 2029

1.4 CRISPR and CRISPR-Associated (Cas) Genes Market Dynamics

1.4.1 CRISPR and CRISPR-Associated (Cas) Genes Industry Trends

1.4.2 CRISPR and CRISPR-Associated (Cas) Genes Market Drivers

1.4.3 CRISPR and CRISPR-Associated (Cas) Genes Market Challenges

1.4.4 CRISPR and CRISPR-Associated (Cas) Genes Market Restraints

1.5 Assumptions and Limitations

1.6 Study Objectives

1.7 Years Considered

2 CRISPR and CRISPR-Associated (Cas) Genes by Type

2.1 CRISPR and CRISPR-Associated (Cas) Genes Market Segment by Type

2.1.1 Genome Editing

2.1.2 Genetic engineering

2.1.3 gRNA Database/Gene Librar

2.1.4 CRISPR Plasmid

2.1.5 Human Stem Cells

2.1.6 Genetically Modified Organisms/Crops

2.1.7 Cell Line Engineering

2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2018, 2022 & 2029)

2.3 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2018-2029)

2.4 India CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2018, 2022 & 2029)

2.5 India CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2018-2029)

3 CRISPR and CRISPR-Associated (Cas) Genes by Application

3.1 CRISPR and CRISPR-Associated (Cas) Genes Market Segment by Application

3.1.1 Biotechnology Companies

3.1.2 Pharmaceutical Companies

3.1.3 Academic Institutes

3.1.4 Research and Development Institutes

3.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2018, 2022 & 2029)

3.3 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2018-2029)

3.4 India CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2018, 2022 & 2029)

3.5 India CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2018-2029)

4 Global CRISPR and CRISPR-Associated (Cas) Genes Competitor Landscape by Company

4.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Company

4.1.1 Global Key Companies of CRISPR and CRISPR-Associated (Cas) Genes, Ranked by Revenue (2022)

4.1.2 Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Player (2018-2023)

4.2 Global CRISPR and CRISPR-Associated (Cas) Genes Concentration Ratio (CR)

4.2.1 CRISPR and CRISPR-Associated (Cas) Genes Market Concentration Ratio (CR) (2018-2023)

4.2.2 Global Top 5 and Top 10 Largest Companies of CRISPR and CRISPR-Associated (Cas) Genes in 2022

4.2.3 Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes Head office and Area Served

4.4 Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Product and Application

4.5 Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Date of Enter into This Industry

4.6 Companies Mergers & Acquisitions, Expansion Plans

4.7 India CRISPR and CRISPR-Associated (Cas) Genes Market Size by Company

4.7.1 Key Players of CRISPR and CRISPR-Associated (Cas) Genes in India, Ranked by Revenue (2022)

4.7.2 India CRISPR and CRISPR-Associated (Cas) Genes Revenue by Players (2021, 2022 & 2023)

5 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region

5.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region: 2018 VS 2022 VS 2029

5.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2018-2029)

5.2.1 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region: 2018-2023

5.2.2 Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2024-2029)

6 Americas

6.1 Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth 2018-2029

6.2 Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type

6.2.1 Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2018-2023)

6.2.2 Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2024-2029)

6.2.3 Americas CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2018-2029)

6.3 Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application

6.3.1 Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2018-2023)

6.3.2 Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2024-2029)

6.3.3 Americas CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2018-2029)

6.4 Americas CRISPR and CRISPR-Associated (Cas) Genes Market Facts & Figures by Country (2018, 2022 & 2029)

6.4.1 United States

6.4.2 Canada

6.4.3 Mexico

6.4.4 Brazil

7 EMEA

7.1 EMEA CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth 2018-2029

7.2 EMEA CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type

7.2.1 EMEA CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2018-2023)

7.2.2 EMEA CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2024-2029)

7.2.3 EMEA CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2018-2029)

7.3 EMEA CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application

7.3.1 EMEA CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2018-2023)

7.3.2 EMEA CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2024-2029)

7.3.3 EMEA CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2018-2029)

7.4 EMEA CRISPR and CRISPR-Associated (Cas) Genes Market Facts & Figures by Country (2018, 2022 & 2029)

7.4.1 Europe

7.4.2 Middle East

7.4.3 Africa

8 China

8.1 China CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth 2018-2029

8.2 China CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type

8.2.1 China CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2018-2023)

8.2.2 China CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2024-2029)

8.2.3 China CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2018-2029)

8.3 China CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application

8.3.1 China CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2018-2023)

8.3.2 China CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2024-2029)

8.3.3 China CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2018-2029)

9 APAC (excluding China)

9.1 APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size YoY Growth 2018-2029

9.2 APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type

9.2.1 APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2018-2023)

9.2.2 APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2024-2029)

9.2.3 APAC CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2018-2029)

9.3 APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application

9.3.1 APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2018-2023)

9.3.2 APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2024-2029)

9.3.3 APAC CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2018-2029)

9.4 APAC CRISPR and CRISPR-Associated (Cas) Genes Market Facts & Figures by Country (2018, 2022 & 2029)

9.4.1 Japan

9.4.2 South Korea

9.4.3 China Taiwan

9.4.4 Southeast Asia

9.4.5 India

10 Key Players Profiles

10.1 Thermo Fisher Scientific

10.1.1 Thermo Fisher Scientific Company Details

10.1.2 Thermo Fisher Scientific Business Overview

10.1.3 Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Introduction

10.1.4 Thermo Fisher Scientific Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)

10.1.5 Thermo Fisher Scientific Recent Development

10.2 Editas Medicine

10.2.1 Editas Medicine Company Details

10.2.2 Editas Medicine Business Overview

10.2.3 Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Introduction

10.2.4 Editas Medicine Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)

10.2.5 Editas Medicine Recent Development

10.3 Caribou Biosciences

10.3.1 Caribou Biosciences Company Details

10.3.2 Caribou Biosciences Business Overview

10.3.3 Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Introduction

10.3.4 Caribou Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)

10.3.5 Caribou Biosciences Recent Development

10.4 CRISPR therapeutics

10.4.1 CRISPR therapeutics Company Details

10.4.2 CRISPR therapeutics Business Overview

10.4.3 CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Introduction

10.4.4 CRISPR therapeutics Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)

10.4.5 CRISPR therapeutics Recent Development

10.5 Intellia therapeutics, Inc.

10.5.1 Intellia therapeutics, Inc. Company Details

10.5.2 Intellia therapeutics, Inc. Business Overview

10.5.3 Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Introduction

10.5.4 Intellia therapeutics, Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)

10.5.5 Intellia therapeutics, Inc. Recent Development

10.6 Cellectis

10.6.1 Cellectis Company Details

10.6.2 Cellectis Business Overview

10.6.3 Cellectis CRISPR and CRISPR-Associated (Cas) Genes Introduction

10.6.4 Cellectis Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)

10.6.5 Cellectis Recent Development

10.7 Horizon Discovery Plc

10.7.1 Horizon Discovery Plc Company Details

10.7.2 Horizon Discovery Plc Business Overview

10.7.3 Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Introduction

10.7.4 Horizon Discovery Plc Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)

10.7.5 Horizon Discovery Plc Recent Development

10.8 Sigma Aldrich

10.8.1 Sigma Aldrich Company Details

10.8.2 Sigma Aldrich Business Overview

10.8.3 Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Introduction

10.8.4 Sigma Aldrich Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)

10.8.5 Sigma Aldrich Recent Development

10.9 Precision Biosciences

10.9.1 Precision Biosciences Company Details

10.9.2 Precision Biosciences Business Overview

10.9.3 Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Introduction

10.9.4 Precision Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)

10.9.5 Precision Biosciences Recent Development

10.10 Genscript

10.10.1 Genscript Company Details

10.10.2 Genscript Business Overview

10.10.3 Genscript CRISPR and CRISPR-Associated (Cas) Genes Introduction

10.10.4 Genscript Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)

10.10.5 Genscript Recent Development

10.11 Sangamo Biosciences Inc.

10.11.1 Sangamo Biosciences Inc. Company Details

10.11.2 Sangamo Biosciences Inc. Business Overview

10.11.3 Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Introduction

10.11.4 Sangamo Biosciences Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)

10.11.5 Sangamo Biosciences Inc. Recent Development

10.12 Lonza Group Limited

10.12.1 Lonza Group Limited Company Details

10.12.2 Lonza Group Limited Business Overview

10.12.3 Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Introduction

10.12.4 Lonza Group Limited Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)

10.12.5 Lonza Group Limited Recent Development

10.13 Integrated DNA Technologies

10.13.1 Integrated DNA Technologies Company Details

10.13.2 Integrated DNA Technologies Business Overview

10.13.3 Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Introduction

10.13.4 Integrated DNA Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)

10.13.5 Integrated DNA Technologies Recent Development

10.14 New England Biolabs

10.14.1 New England Biolabs Company Details

10.14.2 New England Biolabs Business Overview

10.14.3 New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Introduction

10.14.4 New England Biolabs Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)

10.14.5 New England Biolabs Recent Development

10.15 Origene Technologies

10.15.1 Origene Technologies Company Details

10.15.2 Origene Technologies Business Overview

10.15.3 Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Introduction

10.15.4 Origene Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)

10.15.5 Origene Technologies Recent Development

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.2 Data Source

12.2 Disclaimer

12.3 Author Details

FEATURED COMPANIES

CAS

Thermo Fisher Scientific

Editas Medicine

Caribou Biosciences

CRISPR Therapeutics

Intellia Therapeutics Inc

CELLECTIS

Horizon Discovery Plc

Sigma-aldrich

Precision Biosciences

GenScript

Sangamo BioSciences, Inc.

Lonza Group Limited

Integrated DNA Technologies

New England Biolabs

Origene Technologies

List of Tables

Table 1. CRISPR and CRISPR-Associated (Cas) Genes Market Size India VS Global, CAGR (2018 VS 2022 VS 2029)

Table 2. CRISPR and CRISPR-Associated (Cas) Genes Market Trends

Table 3. CRISPR and CRISPR-Associated (Cas) Genes Market Drivers

Table 4. CRISPR and CRISPR-Associated (Cas) Genes Market Challenges

Table 5. CRISPR and CRISPR-Associated (Cas) Genes Market Restraints

Table 6. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 7. India CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 8. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 9. India CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 10. Global Key Companies of CRISPR and CRISPR-Associated (Cas) Genes, Ranked by Revenue (2022) & (US$ Million)

Table 11. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue by Player, (US$ Million), 2018-2023

Table 12. Global CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Player, 2018-2023

Table 13. Global CRISPR and CRISPR-Associated (Cas) Genes Companies Market Concentration Ratio (CR5 and HHI)

Table 14. Global CRISPR and CRISPR-Associated (Cas) Genes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CRISPR and CRISPR-Associated (Cas) Genes as of 2022)

Table 15. Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Headquarters and Area Served

Table 16. Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Product and Application

Table 17. Global Key Players of CRISPR and CRISPR-Associated (Cas) Genes, Date of Enter into This Industry

Table 18. Companies Mergers & Acquisitions, Expansion Plans

Table 19. Key Players of CRISPR and CRISPR-Associated (Cas) Genes in India, Ranked by Revenue (2022) & (US$ Million)

Table 20. India CRISPR and CRISPR-Associated (Cas) Genes Revenue by Players, (US$ Million), 2021, 2022 & 2023

Table 21. India CRISPR and CRISPR-Associated (Cas) Genes Revenue Share by Players, 2021, 2022 & 2023

Table 22. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 23. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2018-2023) & (US$ Million)

Table 24. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Forecast by Region (2024-2029) & (US$ Million)

Table 25. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2018-2023) & (US$ Million)

Table 26. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2024-2029) & (US$ Million)

Table 27. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2018-2023) & (US$ Million)

Table 28. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2024-2029) & (US$ Million)

Table 29. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 30. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2018-2023) & (US$ Million)

Table 31. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2024-2029) & (US$ Million)

Table 32. EMEA CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2018-2023) & (US$ Million)

Table 33. EMEA CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2024-2029) & (US$ Million)

Table 34. EMEA CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2018-2023) & (US$ Million)

Table 35. EMEA CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2024-2029) & (US$ Million)

Table 36. EMEA CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 37. EMEA CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2018-2023) & (US$ Million)

Table 38. EMEA CRISPR and CRISPR-Associated (Cas) Genes Market Size by Country (2024-2029) & (US$ Million)

Table 39. China CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2018-2023) & (US$ Million)

Table 40. China CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2024-2029) & (US$ Million)

Table 41. China CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2018-2023) & (US$ Million)

Table 42. China CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2024-2029) & (US$ Million)

Table 43. China CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 44. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2018-2023) & (US$ Million)

Table 45. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2024-2029) & (US$ Million)

Table 46. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2018-2023) & (US$ Million)

Table 47. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2024-2029) & (US$ Million)

Table 48. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 49. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2018-2023) & (US$ Million)

Table 50. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size by Region (2024-2029) & (US$ Million)

Table 51. Thermo Fisher Scientific Company Details

Table 52. Thermo Fisher Scientific Business Overview

Table 53. Thermo Fisher Scientific CRISPR and CRISPR-Associated (Cas) Genes Product

Table 54. Thermo Fisher Scientific Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023) & (US$ Million)

Table 55. Thermo Fisher Scientific Recent Development

Table 56. Editas Medicine Company Details

Table 57. Editas Medicine Business Overview

Table 58. Editas Medicine CRISPR and CRISPR-Associated (Cas) Genes Product

Table 59. Editas Medicine Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023) & (US$ Million)

Table 60. Editas Medicine Recent Development

Table 61. Caribou Biosciences Company Details

Table 62. Caribou Biosciences Business Overview

Table 63. Caribou Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product

Table 64. Caribou Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023) & (US$ Million)

Table 65. Caribou Biosciences Recent Development

Table 66. CRISPR therapeutics Company Details

Table 67. CRISPR therapeutics Business Overview

Table 68. CRISPR therapeutics CRISPR and CRISPR-Associated (Cas) Genes Product

Table 69. CRISPR therapeutics Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023) & (US$ Million)

Table 70. CRISPR therapeutics Recent Development

Table 71. Intellia therapeutics, Inc. Company Details

Table 72. Intellia therapeutics, Inc. Business Overview

Table 73. Intellia therapeutics, Inc. CRISPR and CRISPR-Associated (Cas) Genes Product

Table 74. Intellia therapeutics, Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023) & (US$ Million)

Table 75. Intellia therapeutics, Inc. Recent Development

Table 76. Cellectis Company Details

Table 77. Cellectis Business Overview

Table 78. Cellectis CRISPR and CRISPR-Associated (Cas) Genes Product

Table 79. Cellectis Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023) & (US$ Million)

Table 80. Cellectis Recent Development

Table 81. Horizon Discovery Plc Company Details

Table 82. Horizon Discovery Plc Business Overview

Table 83. Horizon Discovery Plc CRISPR and CRISPR-Associated (Cas) Genes Product

Table 84. Horizon Discovery Plc Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023) & (US$ Million)

Table 85. Horizon Discovery Plc Recent Development

Table 86. Sigma Aldrich Company Details

Table 87. Sigma Aldrich Business Overview

Table 88. Sigma Aldrich CRISPR and CRISPR-Associated (Cas) Genes Product

Table 89. Sigma Aldrich Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023) & (US$ Million)

Table 90. Sigma Aldrich Recent Development

Table 91. Precision Biosciences Company Details

Table 92. Precision Biosciences Business Overview

Table 93. Precision Biosciences CRISPR and CRISPR-Associated (Cas) Genes Product

Table 94. Precision Biosciences Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023) & (US$ Million)

Table 95. Precision Biosciences Recent Development

Table 96. Genscript Company Details

Table 97. Genscript Business Overview

Table 98. Genscript CRISPR and CRISPR-Associated (Cas) Genes Product

Table 99. Genscript Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023) & (US$ Million)

Table 100. Genscript Recent Development

Table 101. Sangamo Biosciences Inc. Company Details

Table 102. Sangamo Biosciences Inc. Business Overview

Table 103. Sangamo Biosciences Inc. CRISPR and CRISPR-Associated (Cas) Genes Product

Table 104. Sangamo Biosciences Inc. Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023) & (US$ Million)

Table 105. Sangamo Biosciences Inc. Recent Development

Table 106. Lonza Group Limited Company Details

Table 107. Lonza Group Limited Business Overview

Table 108. Lonza Group Limited CRISPR and CRISPR-Associated (Cas) Genes Product

Table 109. Lonza Group Limited Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023) & (US$ Million)

Table 110. Lonza Group Limited Recent Development

Table 111. Integrated DNA Technologies Company Details

Table 112. Integrated DNA Technologies Business Overview

Table 113. Integrated DNA Technologies CRISPR and CRISPR-Associated (Cas) Genes Product

Table 114. Integrated DNA Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023) & (US$ Million)

Table 115. Integrated DNA Technologies Recent Development

Table 116. New England Biolabs Company Details

Table 117. New England Biolabs Business Overview

Table 118. New England Biolabs CRISPR and CRISPR-Associated (Cas) Genes Product

Table 119. New England Biolabs Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023) & (US$ Million)

Table 120. New England Biolabs Recent Development

Table 121. Origene Technologies Company Details

Table 122. Origene Technologies Business Overview

Table 123. Origene Technologies CRISPR and CRISPR-Associated (Cas) Genes Product

Table 124. Origene Technologies Revenue in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023) & (US$ Million)

Table 125. Origene Technologies Recent Development

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

List of Figures

Figure 1. CRISPR and CRISPR-Associated (Cas) Genes Product Picture

Figure 2. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size 2018-2029 (US$ Million)

Figure 4. India CRISPR and CRISPR-Associated (Cas) Genes Market Size, (US$ Million), 2018 VS 2022 VS 2029

Figure 5. India CRISPR and CRISPR-Associated (Cas) Genes Market Size 2018-2029 (US$ Million)

Figure 6. India CRISPR and CRISPR-Associated (Cas) Genes Market Share in Global 2018-2029

Figure 7. CRISPR and CRISPR-Associated (Cas) Genes Report Years Considered

Figure 8. Product Picture of Genome Editing

Figure 9. Product Picture of Genetic engineering

Figure 10. Product Picture of gRNA Database/Gene Librar

Figure 11. Product Picture of CRISPR Plasmid

Figure 12. Product Picture of Human Stem Cells

Figure 13. Product Picture of Genetically Modified Organisms/Crops

Figure 14. Product Picture of Cell Line Engineering

Figure 15. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type in 2022 & 2029

Figure 16. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2018-2029) & (US$ Million)

Figure 17. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2018-2029)

Figure 18. India CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type in 2022 & 2029

Figure 19. India CRISPR and CRISPR-Associated (Cas) Genes Market Size by Type (2018-2029) & (US$ Million)

Figure 20. India CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2018-2029)

Figure 21. Product Picture of Biotechnology Companies

Figure 22. Product Picture of Pharmaceutical Companies

Figure 23. Product Picture of Academic Institutes

Figure 24. Product Picture of Research and Development Institutes

Figure 25. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application in 2022 & 2029

Figure 26. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2018-2029) & (US$ Million)

Figure 27. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2018-2029)

Figure 28. India CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application in 2022 & 2029

Figure 29. India CRISPR and CRISPR-Associated (Cas) Genes Market Size by Application (2018-2029) & (US$ Million)

Figure 30. India CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2018-2029)

Figure 31. The Top 5 and 10 Largest Companies of CRISPR and CRISPR-Associated (Cas) Genes in the World: Market Share by CRISPR and CRISPR-Associated (Cas) Genes Revenue in 2022

Figure 32. Global CRISPR and CRISPR-Associated (Cas) Genes Market Size Market Share by Region: 2018 VS 2022 VS 2029

Figure 33. Global CRISPR and CRISPR-Associated (Cas) Genes Market Share by Region (2018-2029)

Figure 34. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate 2018-2029 (US$ Million)

Figure 35. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2018-2029)

Figure 36. Americas CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2018-2029)

Figure 37. United States CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 38. Canada CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 39. Mexico CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 40. Brazil CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 41. EMEA CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate 2018-2029 (US$ Million)

Figure 42. EMEA CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2018-2029)

Figure 43. EMEA CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2018-2029)

Figure 44. Europe CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 45. Middle East CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 46. Africa CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 47. China CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate 2018-2029 (US$ Million)

Figure 48. China CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2018-2029)

Figure 49. China CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2018-2029)

Figure 50. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate 2018-2029 (US$ Million)

Figure 51. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Share by Type (2018-2029)

Figure 52. APAC CRISPR and CRISPR-Associated (Cas) Genes Market Share by Application (2018-2029)

Figure 53. Japan CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 54. South Korea CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 55. China Taiwan CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 56. Southeast Asia CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 57. India CRISPR and CRISPR-Associated (Cas) Genes Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 58. Thermo Fisher Scientific Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)

Figure 59. Editas Medicine Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)

Figure 60. Caribou Biosciences Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)

Figure 61. CRISPR therapeutics Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)

Figure 62. Intellia therapeutics, Inc. Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)

Figure 63. Cellectis Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)

Figure 64. Horizon Discovery Plc Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)

Figure 65. Sigma Aldrich Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)

Figure 66. Precision Biosciences Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)

Figure 67. Genscript Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)

Figure 68. Sangamo Biosciences Inc. Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)

Figure 69. Lonza Group Limited Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)

Figure 70. Integrated DNA Technologies Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)

Figure 71. New England Biolabs Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)

Figure 72. Origene Technologies Revenue Growth Rate in CRISPR and CRISPR-Associated (Cas) Genes Business (2018-2023)

Figure 73. Bottom-up and Top-down Approaches for This Report

Figure 74. Data Triangulation

Figure 75. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Cell-free DNA Testing Service Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-18B20127

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global cfDNA Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-36H20013

Tue Dec 02 00:00:00 UTC 2025

Add to Cart

Global Strong Cation Exchange Agarose Gel Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-7C20305

Thu Nov 27 00:00:00 UTC 2025

Add to Cart

Global Deoxyadenosine Triphosphate Solution Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-13N20234

Thu Nov 27 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions